CI vs ESPR · P/E 2.4, rev $274.90B vs rev $332.3M
Cigna Corp (CI) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the CI and ESPR stock pages for the full models.
Not investment advice.